Gastric cancer is associated with the poorest prognosis among patients developing malignant pericardial effusion.
Our present study is the first to our knowledge to classify the pericardial fluid from 574 cases in accordance with the recently published ISRSFC, and to present the long-term outcomes of patients with malignant PE at the same time. Moreover, we report for the first time that it is gastric and not lung cancer patients that have the poorest prognosis after the occurrence of malignant PE.
Song et al. (Sun,) studied this question.